(Q36519336)

14 August 2017

1 reference

title

Pharmacological aspects of the treatment of conduct disorder in children and adolescents (English)

1 reference

14 August 2017

0 references

Oleg V Tcheremissine

1

1 reference

14 August 2017

Lori M Lieving

series ordinal

2

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

20

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

549-565

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200620070-00002

14 August 2017

exact match

0 references

cites work

The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200620070-00002

Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200620070-00002

Psychotropic practice patterns for youth: a 10-year perspective

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200620070-00002

Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder

21 January 2018

1 reference

12 December 2020

Let's be clear. Violence is a public health problem

1 reference

12 December 2020

Psychopharmacology for young children: clinical needs and research opportunities

1 reference

12 December 2020

Reboxetine as an optional treatment for hyperkinetic conduct disorder: a prospective open-label trial

1 reference

12 December 2020

Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study

1 reference

12 December 2020

Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings

1 reference

12 December 2020

Delinquency and health among adolescents: multiple outcomes of a similar social and structural process.

1 reference

12 December 2020

Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients

1 reference

12 December 2020

Multisystemic therapy: an effective violence prevention approach for serious juvenile offenders

1 reference

12 December 2020

A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder

1 reference

12 December 2020

The outcome of childhood conduct disorder: implications for defining adult personality disorder and conduct disorder

1 reference

12 December 2020

A double-blind pilot study of risperidone in the treatment of conduct disorder

1 reference

12 December 2020

Violence and illegal drug use among adolescents: evidence from the U.S. National Adolescent Student Health Survey

1 reference

12 December 2020

D-amphetamine and delinquency: hyperkinesis persisting?

1 reference

12 December 2020

Adolescent drug use and other behaviors

1 reference

12 December 2020

Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report.

1 reference

12 December 2020

The new generation of antipsychotic drugs: how atypical are they?

1 reference

12 December 2020

Can a subtype of conduct disorder linked to bipolar disorder be identified? Integration of findings from the Massachusetts General Hospital Pediatric Psychopharmacology Research Program

1 reference

12 December 2020

Extrapyramidal side effects are unacceptable

1 reference

12 December 2020

Long-term experience with lithium treatment in childhood: correlation with clinical diagnosis.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders

1 reference

12 December 2020

Atypical antipsychotics: mechanism of action.

1 reference

12 December 2020

Precursors, consequences and implications for stability and change in pre-adolescent antisocial behaviors.

1 reference

12 December 2020

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design

1 reference

12 December 2020

The effects of anxiety, substance use and conduct disorders on risk of major depressive disorder

1 reference

12 December 2020

Parsing the association between bipolar, conduct, and substance use disorders: a familial risk analysis.

1 reference

12 December 2020

Role of genotype in the cycle of violence in maltreated children

1 reference

12 December 2020

Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.

1 reference

12 December 2020

The overlap of DSM-IV syndromes: potential implications for the practice of polypsychopharmacology, psychiatric drug development, and the human genome project

1 reference

12 December 2020

Structure of problem behavior in adolescence and young adulthood.

1 reference

12 December 2020

Antidepressant treatments and human aggression

1 reference

12 December 2020

Psychopharmacologic treatment in juvenile offenders

1 reference

12 December 2020

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

1 reference

12 December 2020

Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial

1 reference

12 December 2020

Adoption study demonstrating two genetic pathways to drug abuse

1 reference

12 December 2020

Relational aggression, gender, and social-psychological adjustment

1 reference

12 December 2020

Role of noradrenaline in behavioral changes after defeat in male and female rats

1 reference

12 December 2020

Sex differences in aggression: a rejoinder and reprise

1 reference

12 December 2020

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

1 reference

12 December 2020

Biological, psychological and social processes in the conduct disorders

1 reference

12 December 2020

Lithium therapy in aggressive mentally subnormal patients

1 reference

12 December 2020

Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype?

1 reference

12 December 2020

Antisocial and borderline personality disorders: two separate diagnoses or two aspects of the same psychopathology?

1 reference

12 December 2020

Key issues in the development of aggression and violence from childhood to early adulthood

1 reference

12 December 2020

Prevalence, subtypes, and correlates of DSM-IV conduct disorder in the National Comorbidity Survey Replication

1 reference

12 December 2020

Preadolescent conduct disorder behaviors predict relapse and progression of addiction for adolescent alcohol and drug abusers

1 reference

12 December 2020

Why do psychiatric drug research in children?

1 reference

12 December 2020

Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children

1 reference

12 December 2020

A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities

1 reference

12 December 2020

Use of risperidone in pervasive developmental disorders: a case series.

1 reference

12 December 2020

Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses.

1 reference

12 December 2020

Prescribing practices of outpatient child psychiatrists

1 reference

12 December 2020

Molindone hydrochloride treatment of hospitalized children with conduct disorder

1 reference

12 December 2020

Treatment of aggression in children and adolescents with autism and conduct disorder.

1 reference

12 December 2020

Subfactors of DSM-IV conduct disorder: evidence and connections with syndromes from the Child Behavior Checklist

1 reference

12 December 2020

Anxiety and conduct disorders in early onset alcoholism.

1 reference

12 December 2020

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

1 reference

12 December 2020

Hyperglycemia and hypertriglyceridemia secondary to olanzapine

1 reference

12 December 2020

Conduct disorder: practice parameters for assessment, treatment, and prevention

1 reference

12 December 2020

Paediatric psychopharmacology: closing the gap between science and practice.

1 reference

12 December 2020

Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study

1 reference

12 December 2020

Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study

1 reference

12 December 2020

1 reference

12 December 2020

Over the mainstream: diagnostic requirements for biological psychiatric research

1 reference

12 December 2020

[Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia]

1 reference

12 December 2020

The high costs of aggression: public expenditures resulting from conduct disorder.

1 reference

12 December 2020

Treatments for aggressive and antisocial children.

1 reference

12 December 2020

An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder

1 reference

12 December 2020

Medication strategies in childhood aggression: a review

1 reference

12 December 2020

A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children

1 reference

12 December 2020

Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder

1 reference

12 December 2020

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review.

1 reference

12 December 2020

Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study

1 reference

12 December 2020

Treatment of aggressive children with clonidine: results of an open pilot study.

1 reference

12 December 2020

Drug treatment of conduct disorder in young people

1 reference

12 December 2020

Long-term effects of early childhood programs on social outcomes and delinquency.

1 reference

12 December 2020

Fluoxetine in drug-dependent delinquents with major depression: an open trial.

1 reference

12 December 2020

Comparison of two community alternatives to incarceration for chronic juvenile offenders.

1 reference

12 December 2020

Developmental neurobiology: implications for pediatric psychopharmacology

1 reference

12 December 2020

Sturdy childhood predictors of adult antisocial behaviour: replications from longitudinal studies

1 reference

12 December 2020

Gender and aggressive behavior: a meta-analytic review of the social psychological literature

1 reference

12 December 2020

Preventive intervention for maltreated preschool children: impact on children's behavior, neuroendocrine activity, and foster parent functioning.

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Atypical antipsychotic drugs and hyperglycemia in adolescents

1 reference

12 December 2020

Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial.

1 reference

12 December 2020

Citalopram treatment for impulsive aggression in children and adolescents: an open pilot study

1 reference

12 December 2020

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

1 reference

12 December 2020

Divalproex treatment of disruptive adolescents: a report of 10 cases.

1 reference

12 December 2020

Characteristics and outcome of hospitalized adolescent girls with conduct disorder

1 reference

12 December 2020

Olanzapine treatment in adolescents with severe conduct disorder

1 reference

12 December 2020

The pharmacologic treatment of conduct disorders and rage outbursts

1 reference

12 December 2020

Serotonin function and antiaggressive response to fluoxetine: a pilot study.

1 reference

12 December 2020

Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD

1 reference

12 December 2020

A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder

1 reference

12 December 2020

The genetic basis of complex human behaviors

1 reference

12 December 2020

Risperidone and explosive aggressive autism

1 reference

12 December 2020

Lithium treatment of conduct disorders in adolescents

1 reference

12 December 2020

Comorbid disruptive behavior disorder symptoms and their relationship to adolescent alcohol use disorders

1 reference

12 December 2020

Randomized clinical trials, developmental theory, and antisocial youth: guidelines for research.

1 reference

12 December 2020

10.2165/00023210-200620070-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1005755829

0 references

1 reference